Diadon Enterprises © 2018

Kyowa Kirin will build $530M Research Triangle Park biologics facility | Dump Trucks Charlotte NC

A rendered photo of the outside of Kyowa Kirin's new biologics manufacturing facility in Sanford, North Carolina.
A rendering of Kyowa Kirin's new biologics manufacturing facility in Sanford, North Carolina. The $530 million facility will create 100 new jobs and is set to begin operations in 2027. Courtesy of Kyowa Kirin

First published on

Manufacturing Dive

Columbus Ohio Dump Truck Company Brief:

  • Japan-based pharmaceutical columbus oh dump truck company Kyowa Kirin plans to invest up to $530 million to build a new biologic therapies manufacturing facility in Sanford, North Carolina.
  • The plant is on a 75-acre campus in the Research Triangle Park region, with room for future expansion to meet capacity needs, according to a June 10 columbus oh dump truck company press release.
  • The 171,700-square-foot facility, equipped with two reactors used for drug production, is set to break ground later this year and be fully operational by 2027. The plant will create more than 100 new jobs.

Dump Trucks Columbus OH Insight:

Kyowa Kirin is a biotechnology and drug manufacturing columbus oh dump truck company specializing in antibody technologies in core therapeutic areas such as oncology treatments for the central nervous system.

The Sanford facility is part of a larger effort to build out Kyowa Kirin's global manufacturing network, which includes sites in Takasaki and Ube, Japan. 

"The new facility will be scalable with our Takasaki Plant in Japan to help ease technology transfer between the two plants and add production capacity. We believe this will help accelerate drug development and production,” said Toshiyuki Kurata, chief supply chain officer and global manufacturing head at Kyowa Kirin.

KyowaKirin’s new facility aims to accelerate the production of biologic therapies for rare and serious diseases, including antibodies for the company’s planned clinical trials and future commercial use, according to the release.

The manufacturing investment will be supported by $10 million in performance-based state and local incentives over 12 years, according to the release.

KyowaKirin has been growing its North American presence since 2018, which accounted for more than a quarter of KyowaKirin’s global revenues in 2022, according to a columbus oh dump truck company press release. The pharmaceutical columbus oh dump truck company established its North American headquarters in New Jersey in July 2023 and has a research facility in La Jolla, California.

The pharmaceutical columbus oh dump truck company seeks to benefit from the biomanufacturing network established in Research Triangle Park, one of the country’s largest designated research parks. 

Fujifilm contract drugmaker Diosynth Biotechnologies has a 119-acre campus in the park and glass syringe maker Schott Pharma is building a facility for use in GLP-1 therapies, set to start production in 2027. In February, National Resilience announced it’s expanding its fill and finish operations at its Durham site amid a company-wide effort to scale its drug manufacturing capacity.

Construction Dive news delivered to your inbox

Get the free daily newsletter read by industry experts

Daily Dive newsletter example

Editors' picks

  • aerial shot of Tesla's gigafactory in Texas
    Image attribution tooltip
    Courtesy of Tesla, Inc.
    Image attribution tooltip

    Tesla data center delay highlights industrywide challenges

    Elon Musk reportedly fired the director of infrastructure for the firm’s facility in Austin, Texas. Finding a replacement could prove tough, even as more firms enter the space.

    By Sebastian Obando • May 23, 2024
  • A blue and silver train emerges from a stone tunnel.
    Image attribution tooltip
    Courtesy of Gateway Program
    Image attribution tooltip

    Builders embrace the megaproject boom

    There are key ways to de-risk multibillion-dollar jobs like the Gateway Program in New York and New Jersey, according to panelists at a recent webinar.

    By Julie Strupp • May 21, 2024